Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Veracyte Inc (NASDAQ:VCYT)

8.58
Delayed Data
As of 3:59pm ET
 -0.08 / -0.92%
Today’s Change
4.81
Today|||52-Week Range
9.71
+10.85%
Year-to-Date
No recent news for Veracyte Inc.

Today’s Trading

Previous close8.66
Today’s open8.53
Day’s range8.51 - 8.79
Volume49,039
Average volume (3 months)133,188
Market cap$293.3M
Dividend yield--
Data as of 3:59pm ET, 04/27/2017

Growth & Valuation

Earnings growth (last year)+16.15%
Earnings growth (this year)+21.87%
Earnings growth (next 5 years)--
Revenue growth (last year)+31.48%
P/E ratioNM
Price/Sales3.43
Price/Book4.91

Competitors

 Today’s
change
Today’s
% change
OXFDOxford Immunotec Glo...0.000.00%
QTNTQuotient Ltd+0.07+1.08%
CALACalithera Bioscience...-0.40-3.46%
CLDXCelldex Therapeutics...-0.02-0.59%
Data as of 4:15pm ET, 04/27/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$65.1M
Annual profit (last year)-$31.4M
Net profit margin-48.18%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Bonnie H. Anderson
President &
Chief Operating Officer
Christopher M. Hall
Corporate headquarters
South San Francisco, California

Forecasts